BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19205432)

  • 1. [Analysis of ubiquitin-dependent regulation of the monoamine oxidase sensitivity to proteolysis and specific inhibition by pargyline].
    Buneeva OA; Medvedeva MV; Medvedev AE
    Biomed Khim; 2008; 54(6):720-6. PubMed ID: 19205432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ubiquitin causes selective increase in the sensitivity of rat brain mitochondrial monoamine oxidases to various proteases].
    Buneeva OA; Medvedeva MV; Medvedev AE
    Biomed Khim; 2007; 53(5):603-8. PubMed ID: 18078075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ethanol consumption on the sensitivity of rat brain monoamine oxidases to the inhibition by pargyline in vivo and in vitro.
    Panova NG; Axenova LN; Medvedev AE
    Neurobiology (Bp); 2000; 8(3-4):225-30. PubMed ID: 11225512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of ubiquitin into the rat brain mitochondria is accompanied by increased proteolytic digestibility of MAO.
    Buneeva OA; Medvedeva MV; Medvedev AE
    Neurobiology (Bp); 1999; 7(3):257-61. PubMed ID: 10689383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.
    Wang J; Edmondson DE
    Biochemistry; 2011 Apr; 50(13):2499-505. PubMed ID: 21341713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoelectric analysis of 3H-pargyline-labelled monoamine oxidase in rat and carp.
    Obata T; Yamanaka Y; Sho S; Kinemuchi H
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 96(1):91-8. PubMed ID: 1980888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the structures of monoamine oxidases A and B in rat clonal cell lines.
    Cawthon RM; Breakefield XO
    Biochem Pharmacol; 1983 Feb; 32(3):441-8. PubMed ID: 6847697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of [3H] pargyline to rat liver mitochondrial monoamine oxidase.
    Parkinson D; Callingham BA
    J Pharm Pharmacol; 1980 Jan; 32(1):49-54. PubMed ID: 6102127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophoretic analysis of 3H-pargyline-labeled monoamine oxidases A and B from human and rat cells.
    Costa MR; Breakefield XO
    Mol Pharmacol; 1980 Mar; 17(2):199-205. PubMed ID: 7393204
    [No Abstract]   [Full Text] [Related]  

  • 12. The insertion of monoamine oxidase A into the outer membrane of rat liver mitochondria.
    Zhuang ZP; Marks B; McCauley RB
    J Biol Chem; 1992 Jan; 267(1):591-6. PubMed ID: 1309756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A.
    Hurst JH; Kulakowski EC
    Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
    Denney RM; Fritz RR; Patel NT; Widen SG; Abell CW
    Mol Pharmacol; 1983 Jul; 24(1):60-8. PubMed ID: 6191193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart.
    Raffel DM; Wieland DM
    J Nucl Med; 1999 Feb; 40(2):323-30. PubMed ID: 10025842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW; Wong CJ; Hemrick-Luecke SK
    Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase A and monoamine oxidase B activities are catalyzed by different proteins.
    Smith D; Filipowicz C; McCauley R
    Biochim Biophys Acta; 1985 Sep; 831(1):1-7. PubMed ID: 3899177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the structure of A and B forms of human monoamine oxidase.
    Cawthon RM; Pintar JE; Haseltine FP; Breakefield XO
    J Neurochem; 1981 Aug; 37(2):363-72. PubMed ID: 7264664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes.
    Cesura AM; Imhof R; Takacs B; Galva MD; Picotti GB; Da Prada M
    J Neurochem; 1988 Apr; 50(4):1037-43. PubMed ID: 3126263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.